What are the implications of HPV in the biology of Head and Neck Cancer?

Similar documents
HPV and Head and Neck Cancer: What it means for you and your patients

Update of the role of Human Papillomavirus in Head and Neck Cancer

Objectives. HPV Classification. The Connection Between Human Papillomavirus and Oropharyngeal Cancer 6/19/2012

HPV is the most common sexually transmitted infection in the world.

Notice of Faculty Disclosures

Evaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S.

Human Papillomavirus

Head and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S.

Oral HPV infection and the changing epidemiology in head and neck cancer

Concern for recurrence Stable virus especially in freeze dried form High infectivity in humans Vaccine supplies are limited No specific antiviral

Human Papillomavirus in Head and Neck Cancer

HPV-Related Head and Neck Squamous Cancers

Focus. International #52. HPV infection in High-risk HPV and cervical cancer. HPV: Clinical aspects. Natural history of HPV infection

HPV-Associated Disease and Prevention

2 HPV E1,E2,E4,E5,E6,E7 L1,L2 E6,E7 HPV HPV. Ciuffo Shope Jablonska HPV Zur Hausen HPV HPV16. HPV-genome.

MANAGEMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANER: HPV AND NON-HPV MEDIATED CANCERS

HPV Infection and associated disease among HIV positive individuals. Admire Chikandiwa. Wits RHI

SCCPS Scientific Committee Position Paper on HPV Vaccination

Gynecologic Oncology Overview Staging updates and Soap Box Issues

De-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist

Pathology of the Cervix

CELL BIOLOGY - CLUTCH CH CANCER.

HPV Analysis of Head and Neck Squamous Cell Carcinomas based on Fine-Needle. Aspiration Specimens. William H. Westra M.D.

Cervical Dysplasia and HPV

Head and Neck SCC. HPV in Tumors of the Head and Neck. Overview. Role of HPV in Pathogenesis of Head & Neck Tumors

Human Papillomavirus and Head and Neck Cancer. Ed Stelow, MD

Utilization of the Biomarkers to Improve Cervical Cancer Screening

HPV and Lower Genital Tract Disease. Simon Herrington University of Edinburgh, UK Royal Infirmary of Edinburgh, UK

Update on HPV Testing. Robert Schlaberg, M.D., Dr. med., M.P.H. Assistant Professor, University of Utah Medical Director, ARUP Laboratories

Towards the elimination of HPV

Association of Human Papilloma Virus Type 16 and 18 with Squamous Cell Carcinoma in Oral Cavity and Oropharynx

New Paradigms for Treatment of. Erminia Massarelli, MD, PHD, MS Clinical Associate Professor

Available online at WSN 76 (2017) EISSN HPV Vaccines. Katarzyna Sitarz

Reporting HPV related carcinomas of the head and neck. dr. Nina Zidar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia

HUMAN GENOME. Length of DNA/chromosome Six feet. 30,000 genes. 23 chromosomes

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

Update on Oral HPV Service and Related Research K Cuschieri, presented at Shine Meeting 25/09/12.

Case Report Concurrent Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx in a Married Couple

OROPHARYNX CANCER. Anthony Zeitouni, MD, FRCSC. Co-Lead, Head Neck Cancer Rossy Cancer Network

chapter 4. The effect of oncogenic HPV on transformation zone epithelium

HPV infections and potential outcomes

A Case Review: Treatment-Naïve Patient with Head and Neck Cancer

CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.

The Biology of HPV Infection and Cervical Cancer

HUMAN PAPILLOMAVIRUS

Chapter 2 Molecular Features and Treatment Modalities of Classic Versus Human Papilloma Virus-Associated Head and Neck Cancer

HPV AND CERVICAL CANCER

Battle against Human Papilloma Virus (HPV): Expanded Vaccine Recommendations

F.C. Shakhtatinskaya, L.S. Namazova-Baranova, V.K. Tatochenko, D.A. Novikova, T.E. Tkachenko

California Association for Medical Laboratory Technology

HIV-infected men and women. Joel Palefsky, M.D. University of California, San Francisco

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Human Papillomaviruses: Biology and Laboratory Testing

Done by khozama jehad. Neoplasia of the cervix

HPV Epidemiology and Natural History

Trends in HPV-Associated Cancers United States,

HPV FREE IDAHO. Fundamentals of HPV Bill Atkinson, MD MPH

Clinical overview of GSK s AS04 adjuvanted vaccine: data up to 6.4 years

Focus. A case. I have no conflicts of interest. HPV Vaccination: Science and Practice. Collaborative effort with Karen Smith-McCune, MD, PhD 2/19/2010

An update on the Human Papillomavirus Vaccines. I have no financial conflicts of interest. Case 1. Objectives 10/26/2016

Chapter 9, Part 1: Biology of Cancer and Tumor Spread

Bottoms UP HIV and Anal Cancer from Screening to Prevention

Human Papilloma Virus (HPV): Associated Diseases and Vaccine Recommendations

Following microtrauma, HPV s bind to the basement membrane, infect basal cells, and replicate in suprabasal cells

Disclosures. HPV and Head and Neck Cancer NONE 5/8/2018

Under-appreciated Cancers Associated with HPV Texas Immunization Summit

A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Follow-up for Cervical Cancer

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

Humaan Papillomavirus en hoofd/halskanker. Pol Specenier

Laboratory Considerations

Smoking, human papillomavirus infection, and p53 mutation as risk factors in oropharyngeal cancer: a case-control study

HPV vaccine perspectives Dr. David Prado Cohrs

Can HPV, cervical neoplasia or. HIV transmission?

HPV and Oral Cancer. Oral Cancer

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Prevalence Of Precancerous Lesions Of The Uterine Cervix

Oral Cancer and Common Oral Lesions seen in HIV Seropositive Patients. Gwen Cohen Brown DDS, FAAOMP Professor New York City College of Technology

INTRODUCTION HUMAN PAPILLOMAVIRUS

Chapter 3. Neoplasms. Copyright 2015 Cengage Learning.

New Era of Precision Medicine for Head and Neck Cancer

Written By: Dr. Sara Solomon BSc Physical Therapy, DMD

Human papilloma viruses and cancer in the post-vaccine era

Survival Benefit of Chemotherapy in Oropharyngeal Cancer Patients Treated with. Surgery and Post-Operative Radiation. Fawaz Mohammed Makki

Role of Human Papilloma Virus Infection in Cancer of Cervix

Welcome. THE ROLE OF oncofish cervical ASSESSMENT OF CERVICAL DYSPLASIA. March 26, 2013

Promise of reduced HPV associated

Human Papillomavirus Testing in Head and Neck Carcinomas

Development of Carcinoma Pathways

HPV Transmission. Rachel Winer, PhD, MPH Department of Epidemiology University of Washington

Prophylactic HPV Vaccines. Margaret Stanley Department of Pathology Cambridge

Viruses Tomasz Kordula, Ph.D.

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

Background HPV causes virtually all cervical cancers HPV-16, Integration of viral oncogenes E6 and E7 Relationship between HPV and cervical cancer wou

Diseases of oral cavity

HPV and PREGNANCY Arsenio Spinillo,, MD

The Global Burden of HPV Related Cancers and Their Prevention

Exemplar for Internal Achievement Standard. Biology Level 2

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV?

He Said, She Said: HPV and the FDA. Audrey P Garrett, MD, MPH June 6, 2014

The HPV Cancer Epidemic: Why We Must Vaccinate Our Boys Acadiana Potpourri Lafayette, Louisiana August 19, 2017

Transcription:

What are the implications of HPV in the biology of Head and Neck Cancer? Raquel Ajub Moyses Friday, August 2nd, 2013

Disclosure Raquel Ajub Moyses has no significant financial relationship with any commercial or proprietary entity that produces healthcare-related products and/or services relevant to the content of this presentation.

Overview HPV structure Infection Carcinogenesis Implications clinical presentation diagnosis prognosis / response to treatment follow up Prevention Immunotherapy Other treatment strategies

HPV structure Small, nonenveloped DNA viruses more than 200 subtypes 30 suptypes: muccosal and genital Low risk: 6,11,42,43,44 High risk: 16, 18, 31, 33, 35, 45, 51, 52, 56 Virology 2004 Proc Natl Acad Sci U S A. 1994

Head and Neck Pathol, 2012 Int J Cancer. 2002 Biochem J, 2013 HPV structure Double-stranded genome encodes 6 early proteins (E1, E2, E4, E5, E7) 2 late proteins (L1 and L2) Virus DNA in host cell: Episomal (extrachromosomal) Integrated Mixed forms of both Once integrated: selective growth advantage for the affected cells

HPV structure Head and Neck Pathol, 2012 Biochem J, 2013

Vaccine, 2006 Head and Neck Pathol, 2012 Infection Trauma or erosion infection of undifferentiated basal cells of epithelia E1 and E2 proteins expressed infected cell migrates toward the superficial layers E6 and E7 oncogenes expressed - retain the differentiating host keratinocyte in a state favorable for amplification of viral genome granular epithelial layer - L1 and L2 (capsid proteins) expressed and encapsulate the newly synthesized viral genomes

Annual Rev Pathol. 2009 Head and Neck Pathol, 2012 Infection Affinity for tonsillar crypts patches of stratified squamous nonkeratinizing epithelium patches of reticulated epithelium (porous BM) intimate contact between effector cells of immune responses facilitate direct transport of antigens synthesize secretory component continually contain a pool of immunoglobulins

Infection HPV infections Cleared by the immune system Latent infections of the basal cell layer - low viral copy numbers maintained indefinitely injury or immunosuppression induces active infection Integration of viral DNA into host genome: strong predictor of risk of progression to neoplastic disease Head and Neck Pathol, 2012

Biochem J, 2013 Otolaryngol Clin N Am, 2013 Production of E6 and E7 Carcinogenesis E6: degradation of p53 prevents apoptosis E7: inactivation of Retinoblastoma family tumor suppressor proteins (prb, p130, p107) cell cycle progression ---- compensatory overexpression of p16 proteins

Carcinogenesis Production of E5 enhances EGFR pathway activation blocks ATPase and aids in recycling of EGFR and its expression on the cellular surface Enhances cell proliferation through downregulation of tumor suppressor p21/27 Otolaryngol Clin N Am, 2013

Clinical presentation Tonsils and Base of Tongue Other sites Implications May affect mucosa outside the oropharyngeal lymphoepithelium under rare circumstances. Laboratory methodology (PCR), amount of HPV signal is below biologic significance - simple infection without cancer transformation. Misclassification of site Otolaryngol Clin N Am, 2013

Clinical presentation Implications early occult lesions crypts late symptoms, reffered otalgia rare pre-cancerous lesions (also from cervix) no field cancerization (multifocal lesions) large interval between presentation and diagnosis BOT palpation! Otolaryngol Clin N Am, 2013

Implications Clinical presentation Risk factors/epidemiological profile Whites Younger Men Multiple orogenital sexual partners Non-smokers High social economic status Marijuana? Otolaryngol Clin N Am, 2013 N Engl J Med 2007

Diagnosis Implications WHY? HOW? WHEN?

Diagnosis Why? Implications Powerful biomarker for prediction of prognosis College of American Pathologists & American Joint Committee on Cancer routine HPV testing: standard pathologic evaluation of resected oropharyngeal squamous cell carcinomas for the purpose of molecular tumor staging Help in difficult diagnostic dilemmas Finding occult primary tumor differentiate 2 nd primary metastatic disease to lungs treatment strategies? posttreatment surveillance? AJCC cancer staging manual, 2011 College of American Pathologists; 2011. Cancer 2010 Clin Cancer Res 2003 Clin Cancer Res 2007 Am J Surg Pathol 2009 Hum Pathol 2010

Diagnosis How? Morphology Implications Otolaryngol Clin N Am, 2012

Diagnosis How? Implications Gold Standard: Evidence for transcriptional activation of the viral oncoproteins E6 and E7 recognizes the presence of HPV discerns its tumorigenic potential Immunohistochemical probes for E6 and E7 proteins Difficult to get reliable probes Detection of E6/E7 mrna Usually fresh frozen samples Recently from FFPE samples still difficult for the clinical setting Otolaryngol Clin N Am, 2012

Implications Diagnosis How? Strategies for detection of The actual presence of HPV DNA Postintegration transcription of viral E6 and/or E7 messenger RNA (mrna) The viral oncoproteins E6 and E7 Altered expression of cellular proteins (overexpression of the p16 protein) Otolaryngol Clin N Am, 2012

Diagnosis How? Implications Otolaryngol Clin N Am, 2012

Diagnosis When? not for non-op sites compulsory in research ethical implications Implications

Prev med 2011 NEJM, 2010 JCO, 2011 Semin Radiat Oncol. 2012 Survival Implications Increased global and disease-free survival 3 years: 84% vs 57% 4 fold increase in median survival HPV+ tumors with increasing survival while HPV- estable

Implications NEJM, 2010

Implications NEJM, 2010

Implications NEJM, 2010

Why better outcomes? Implications less disrupted genetic milieu in HPV+ tumors wild type p53 Overstaged node metastasis? not valid dogma of planned neck dissection after non-surgical treatment when disease stage is N2 or above No cancerization field Imunosurveillance for viral antigens? Curr Opin Oncol. 2009 J Natl Cancer Inst. 2000 J Clin Oncol. 2006

Follow up Recurrences Implications Semin Radiat Oncol. 2012

Follow up Second primary tumors Implications Cancer, 2013

Follow up Implications Distant Metastasis Similar rates, different natural courses: May occur after long survival Disseminating phenotype Prolonged survival after salvage for DM Oral Oncology, 2013

Follow up Distant Metastasis Implications Oral Oncology, 2013

Sexual Habits - Moralism? Prevention

Prevention HPV Vaccines Quadrivalent (Gardasil ): HPV-6, -11, -16, -18 APPROVAL: 2006: 9-26y CA cervix, vagina and vulva 2009: 9-26y genital warts 2011: anal cancer EFFICACY >98% if no previous contact 50-78% if previous contact US FDA Centers for Disease Cintrol and Prevention Drugs, 2010 BMC Infect Dis, 2011

Prevention HPV Vaccines Bivalente (Cervarix ): HPV-16, -18 APPROVAL: 2009: CA cérvix EFFICACY >97% if no previous contact No protection agains genital warts US FDA BMC Infect Dis, 2011

HPV Vaccines Prevention Dificulties to be implemented: Parents misconception of stimulating sexual activity Costs Benefits will not be noted for several decades Change in HPV oral prevalence? Change in HPV+ NHC?

Prevention

Immunotherapy Importance of a functioning immune system against HPV Most immune-competent individuals are able to clear the infection Only 10% of infected individuals will develop HPV-related lesions Immunocompromised individuals: increased rates of HPV infections and of HPV-related diseases Otolaryngol Clin N Am, 2012

Immune response Immunotherapy humoral responses: Ab against L1 weak, inconsistent, and may not protect against future reinfection 30% to 50% patients with HPV-associated cancer with detectable antibodies Antibody titers can persist for many years even after the infection is cleared (useful marker for past infection rather than current) Ab against E6 (HNC) Otolaryngol Clin N Am, 2012

Immune response Immunotherapy Cell mediated HPV-specific CD41 and CD81 T cells critical in clearing established lesions Patients with evidence of previously cleared HPV-16 infections have strong detectable T-cell responses to viral proteins Otolaryngol Clin N Am, 2012

Immunotherapy Preventive vs Therapeutic vaccines Otolaryngol Clin N Am, 2012

Immunotherapy Preventive vs Therapeutic vaccines identification of tumor-specific antigens -specificity of the targeted immune response E6 and E7 proteins: good model Viral (foreign) more immunogenic than a self protein Expressed by all cells infected by the virus (cancerous or not) Cancer cell not likely to downregulate de expression, because they are necessary to maintain the malignant phenotype Otolaryngol Clin N Am, 2012

Immunotherapy

Immunotherapy

N Engl J Med 2010 Eur J Cancer 2010 Otolaryngol Clin N Am, 2012 Other Strategies EGFR Inhibitors Increased EGFR expression in HPV positive tumors Paradox: HPV positivity: good outcome in oropharyngeal EGFR expression: independent risk factor for poor prognosis in HNC

Other Strategies

Immunotherapy

N Engl J Med 2010 Eur J Cancer 2010 Otolaryngol Clin N Am, 2012 Other Strategies VEGF inhibitor E6, E7: upregulation of VEGF E5: increases VEGF expression through EGFR pathway Paradox: HPV positivity: good outcome in oropharyngeal EGFR expression: independent risk factor for poor prognosis in HNC

Other Strategies COX-2 inhibitor COX-2 enzyme overexpressed in HPV-related precancerous cervical lesions and recurrent respiratory papillomas Gynecol Oncol 2007 Mol Med, 2007

Other Strategies COX-2 inhibitor COX-2 enzyme overexpressed in HPV-related precancerous cervical lesions and recurrent respiratory papillomas Gynecol Oncol 2007 Mol Med, 2007

Other Strategies

Feliz serás e sábio terás sido se a morte, quando vier, não te puder tirar senão a vida. Francisco de Quevedo